Study is first to show feasibility and efficacy of a new use for autologous stem cell transplant. For the first...
When aggressive, malignant tumors appear in more than one location in the brain, patient survival tends to be significantly shorter than when the disease starts as a single tumor, even though patients in both groups undergo virtually identical treatments, according to research at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Research Institute.
A new study argues that prolonged chemotherapy decreases the development of new brain cells, and disrupts ongoing brain rhythms in the part of the brain responsible for making new memories.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
Researchers have discovered a biomarker which predicts whether glioblastoma brain tumors will respond to chemotherapy.
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain.
Researchers report they might have discovered why some people are resistant to standard treatments for brain cancer, and it's in their DNA.
Researchers have discovered a way in which to sensitize drug-resistant human glioblastoma cells to chemotherapy.
A lipid nanocarrier small enough to pass the blood-brain barrier could be an effective method for delivering chemotherapy medications to help fight glioblastoma brain tumors, a new study reports.
Glioblastmoa brain cancer patients who received an experimental vaccines in combination with chemotherapy showed improved suitability and tolerated the treatment well, a new study reports.
Temozolomide, a chemotherapy drug used to treat brain cancer, could increase risks of developing depression by preventing neurogenesis, a new study reports.
Arsenic trioxide, a treatment used for acute promyelocytic leukemia, may help extend lifespan in patients with glioblastoma brain cancer, a new study reports.
